Who are Docusate natrium and sorbitol's main competitors?

No direct comparators detected in our index.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/docusate-natrium-and-sorbitol.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-14 · How we verify

Docusate natrium and sorbitol — Competitive Intelligence Brief

Docusate natrium and sorbitol (Docusate natrium and sorbitol) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Laxative combination (stool softener + osmotic laxative). Area: Gastroenterology.

marketed Laxative combination (stool softener + osmotic laxative) Gastroenterology Small molecule Live · refreshed every 30 min

Target snapshot

Docusate natrium and sorbitol (Docusate natrium and sorbitol) — Oslo University Hospital. Docusate sodium acts as a stool softener by reducing surface tension of feces, while sorbitol acts as an osmotic laxative to increase water retention in the bowel.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Docusate natrium and sorbitol TARGET	Docusate natrium and sorbitol	Oslo University Hospital	marketed	Laxative combination (stool softener + osmotic laxative)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Laxative combination (stool softener + osmotic laxative) class)

Oslo University Hospital · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Docusate natrium and sorbitol — Competitive Intelligence Brief. https://druglandscape.com/ci/docusate-natrium-and-sorbitol. Accessed 2026-05-14.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab